Share on LinkedInShare on LinkedIn

ARTICLE · 07 JULY 2014

USPTO Extends Deadline To Comment On Subject Matter Eligibility Analysis

A panel of experts discussed the "Guidance for Determining Subject Matter Eligibility of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products".

United StatesIntellectual Property

Yesterday at BIO's session entitled "Patent-Eligibility from the Trenches: Practical Implications of the Supreme Court's Prometheus (Mayo) and Myriad Decisions" a panel of experts and an engaged audience discussed the controversial USPTO "Guidance for Determining Subject Matter Eligibility of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (2014 Guidance) and its implications for the biotechnology and pharmaceutical industries. The USPTO's Former Acting Director Terry Stanek Rea announced that based on information gleaned from a prior BIO panel, the USPTO is open to revising its 2014 Guidance that called into question the patent-eligibility of many biotechnology and pharmaceutical inventions and is accepting public comments until July 31, 2014.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from